Wuhan, China

Tongtong Li

This inventor holds 2 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Waterstone Pharmaceuticals (Wuhan) Co., Ltd., Waterstone Pharmaceuticals(wuhan) Co., Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tongtong Li. Retrieved from https://idiyas.com/inventor/tongtong-li-np3t404i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Tongtong Li in Treating Hyperuricemia

Introduction

Tongtong Li is an accomplished inventor based in Wuhan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hyperuricemia. His innovative work has led to the development of a patent that addresses this medical condition.

Latest Patents

Tongtong Li holds a patent for "Polymers, compositions and methods for treating hyperuricemia." This patent provides polymers and compositions, as well as methods for preparing these polymers and compositions. Additionally, it outlines a method for using these polymers or compositions to bind uric acid or its precursors, and for treating hyperuricemia, gout, and diseases caused by hyperuricemia. He has 1 patent to his name.

Career Highlights

Throughout his career, Tongtong Li has worked with Waterstone Pharmaceuticals (Wuhan) Co., Ltd. and Waterstone Pharmaceuticals Co., Ltd. His experience in these companies has allowed him to apply his innovative ideas in practical settings, contributing to advancements in pharmaceutical treatments.

Collaborations

Some of his notable coworkers include Youcheng Zhou and Yan Li, who have collaborated with him on various projects.

Conclusion

Tongtong Li's contributions to the field of pharmaceuticals, particularly through his patent for treating hyperuricemia, highlight his role as an innovative inventor. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…